Loading clinical trials...
Loading clinical trials...
The purpose of the study is to explore association patterns between digital outcome assessments from Konectom and MRI measures of brain tissue damage.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Biogen
NCT07225361 · Multiple Sclerosis, Multiple Sclerosis (MS) - Relapsing-remitting
NCT05359653 · Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, and more
NCT07376772 · Multiple Sclerosis (MS) - Relapsing-remitting, Upper Extremity Dysfunction
NCT04819737 · Multiple Sclerosis (MS)
NCT07360977 · PARKINSON DISEASE (Disorder), Multiple Sclerosis (MS) - Relapsing-remitting, and more
Multiple Sclerosis Centre
Dresden
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions